Icure Pharm. Inc. (KOSDAQ:A175250) agreed to acquire 90% stake in OTKCNT Co., Ltd. from an unknown seller for KRW 9 billion on April 5, 2019. As per the terms, the consideration will be paid in cash. For the year ending 2018, OTKCNT had total assets of KRW 10.8 billion, total capital of KRW 6.53 billion, total sales of KRW 25 billion and net profit of KRW 1.15 billion. The transaction is expected to be completed by May 3, 2019. Icure Pharm. Inc. (KOSDAQ:A175250) cancelled the acquisition of 90% stake in OTKCNT Co., Ltd. from an unknown seller on April 5, 2020.